Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Effect of Mucogyne® Ovule on Wound Healing (ORIGYNE)
Sponsor: Biocodex
Summary
This clinical investigation is a post-market clinical follow-up performed to confirm the performance and safety of the Mucogyne® ovule medical device in promoting the process of wound healing, when used in accordance with its approved labelling, in the context of local cervicovaginal surgery.
Official title: ORIGYNE (MUCO232) - the Effect of Mucogyne® Ovule on Wound Healing
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
144
Start Date
2024-10
Completion Date
2025-11
Last Updated
2024-09-05
Healthy Volunteers
No
Conditions
Interventions
Mucogyne Ovule
In Mucogyne group, patient will receive 2 boxes of Mucogyne® ovule. 24 hours after intervention, the patient will apply Mucogyne® ovule, 1 ovule per day for 10 days, to be repeated as needed (for practices' homogenisation, after the 10th day, it is recommended to apply one ovule every second day, until EOS visit)
Locations (3)
CHU Amiens-Picardie
Amiens, France
CHU Besançon
Besançon, France
Hôpital Nord Franche-Comté
Trévenans, France